Please note that the copy function is not enabled for this field.
If you wish to
modify
existing outcomes, please copy and paste the current outcome text into the Update field.
LOGIN
CREATE ACCOUNT
MY TRIALS
LOGIN
CREATE ACCOUNT
MY TRIALS
REGISTER TRIAL
FAQs
HINTS AND TIPS
DEFINITIONS
Register a trial
The ANZCTR website will be unavailable from 1pm until 3pm (AEDT) on Wednesday the 30th of October for website maintenance. Please be sure to log out of the system in order to avoid any loss of data.
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been endorsed by the ANZCTR. Before participating in a study, talk to your health care provider and refer to this
information for consumers
Trial details imported from ClinicalTrials.gov
For full trial details, please see the original record at
https://clinicaltrials.gov/study/NCT04383652
Registration number
NCT04383652
Ethics application status
Date submitted
7/05/2020
Date registered
12/05/2020
Titles & IDs
Public title
Collection of Coronavirus COVID-19 Outbreak Samples in New South Wales
Query!
Scientific title
Collection of Coronavirus COVID-19 Outbreak Samples in New South Wales
Query!
Secondary ID [1]
0
0
VISP2005
Query!
Universal Trial Number (UTN)
Query!
Trial acronym
COSiN
Query!
Linked study record
Query!
Health condition
Health condition(s) or problem(s) studied:
COVID
0
0
Query!
Condition category
Condition code
Infection
0
0
0
0
Query!
Other infectious diseases
Query!
Intervention/exposure
Study type
Observational
Query!
Patient registry
Query!
Target follow-up duration
Query!
Target follow-up type
Query!
Description of intervention(s) / exposure
Other interventions - Biological sample and clinical data collection
Adult cohort - 1. Diagnosed with SARS-CoV-2 infection (COVID-19; by a registered diagnostic facility)
2. Age 16 years or older
3. Have provided informed consent
Blood samples and clinical data related to COVID19 diagnosis, symptoms, and outcomes will be collected.
Paediatric cohort - 1. Diagnosed with SARS-CoV-2 infection (COVID-19; by a registered diagnostic facility)
2. Age less than 16 years
3. Parent or caregiver has provided informed consent Blood samples and clinical data related to COVID19 diagnosis, symptoms, and outcomes will be collected.
Other interventions: Biological sample and clinical data collection
Plasma and serum will be collected at day 0, day 7, day 14, 1 month and 4 months post diagnosis. Clinical data related to COVID-19 diagnosis, symptoms, and outcomes will be collected.
Query!
Intervention code [1]
0
0
Other interventions
Query!
Comparator / control treatment
Query!
Control group
Query!
Outcomes
Primary outcome [1]
0
0
Coronavirus sequencing
Query!
Assessment method [1]
0
0
The viruses will be sequenced to to help understand epitope specificity
Query!
Timepoint [1]
0
0
4 months post COVID-19 diagnosis.
Query!
Secondary outcome [1]
0
0
Coronavirus culturing
Query!
Assessment method [1]
0
0
The viruses will then be either cultured to study the immune response against them in culture.
Query!
Timepoint [1]
0
0
4 months post COVID-19 diagnosis.
Query!
Eligibility
Key inclusion criteria
* Main cohort
1. Diagnosed with CoV-SARS-2 infection
2. 16 years of age or older
3. Have provided informed consent Paediatric cohort
<!-- -->
1. Diagnosed with CoV-SARS-2 infection
2. Less than 16 years of age
3. Informed consent provided by parent or caregiver
Query!
Minimum age
No limit
Query!
Query!
Maximum age
No limit
Query!
Query!
Sex
Both males and females
Query!
Can healthy volunteers participate?
No
Query!
Key exclusion criteria
Main cohort
<!-- -->
1. 15 years of age or younger
2. Inability or unwillingness to provide informed consent or abide by the requirements of the study Paediatric cohort
<!-- -->
1. 16 years of age or older
2. Inability or unwillingness of parent or caregiver to provide informed consent or abide by the requirements of the study -
Query!
Study design
Purpose
Query!
Duration
Query!
Selection
Query!
Timing
Prospective
Query!
Statistical methods / analysis
Query!
Recruitment
Recruitment status
UNKNOWN
Query!
Data analysis
Query!
Reason for early stopping/withdrawal
Query!
Other reasons
Query!
Date of first participant enrolment
Anticipated
Query!
Actual
6/05/2020
Query!
Date of last participant enrolment
Anticipated
Query!
Actual
Query!
Date of last data collection
Anticipated
30/06/2022
Query!
Actual
Query!
Sample size
Target
200
Query!
Accrual to date
Query!
Final
Query!
Recruitment in Australia
Recruitment state(s)
NSW
Query!
Recruitment hospital [1]
0
0
NSW Health Pathology - Randwick
Query!
Recruitment hospital [2]
0
0
Prince of Wales Hospital - Randwick
Query!
Recruitment hospital [3]
0
0
Sydney Children's Hospital - Randwick
Query!
Recruitment hospital [4]
0
0
Blacktown Hospital - Blacktown
Query!
Recruitment hospital [5]
0
0
Royal Prince Alfred Hospital - Camperdown
Query!
Recruitment hospital [6]
0
0
St Vincent's Hospital - Darlinghurst
Query!
Recruitment hospital [7]
0
0
Northern Beaches Hospital - Frenchs Forest
Query!
Recruitment hospital [8]
0
0
Royal North Shore Hospital - Saint Leonards
Query!
Recruitment hospital [9]
0
0
Westmead Hospital - Westmead
Query!
Recruitment postcode(s) [1]
0
0
2031 - Randwick
Query!
Recruitment postcode(s) [2]
0
0
- Blacktown
Query!
Recruitment postcode(s) [3]
0
0
- Camperdown
Query!
Recruitment postcode(s) [4]
0
0
- Darlinghurst
Query!
Recruitment postcode(s) [5]
0
0
- Frenchs Forest
Query!
Recruitment postcode(s) [6]
0
0
- Saint Leonards
Query!
Recruitment postcode(s) [7]
0
0
- Westmead
Query!
Funding & Sponsors
Primary sponsor type
Government body
Query!
Name
Kirby Institute
Query!
Address
Query!
Country
Query!
Ethics approval
Ethics application status
Query!
Summary
Brief summary
The objectives of this study are to characterise immune responses in people with CoV-SARS-2 infection and use this knowledge to advance vaccine design, treatment options, and diagnostic reagents. Eligible participants will include people diagnosed with SARS-CoV-2 infection, and may include recently returned travellers and non-travellers in the community presenting to tertiary hospital healthcare facilities. Recruitment will be opportunistic, and sampling intensity may vary depending on the phase of the outbreak. Participants can be enrolled at any timepoint (up to 6 months) following diagnosis of SARS-CoV-2 infection (COVID-19). Blood samples and clinical data will be collected.
Query!
Trial website
https://clinicaltrials.gov/study/NCT04383652
Query!
Trial related presentations / publications
Query!
Public notes
Query!
Contacts
Principal investigator
Name
0
0
Marianne Martinello
Query!
Address
0
0
Kirby Institute, UNSW Sydney
Query!
Country
0
0
Query!
Phone
0
0
Query!
Fax
0
0
Query!
Email
0
0
Query!
Contact person for public queries
Name
0
0
Rowena Bull
Query!
Address
0
0
Query!
Country
0
0
Query!
Phone
0
0
0293850900
Query!
Fax
0
0
Query!
Email
0
0
[email protected]
Query!
Contact person for scientific queries
Data sharing statement
Will individual participant data (IPD) for this trial be available (including data dictionaries)?
No
Query!
No/undecided IPD sharing reason/comment
Access to samples and data is governed by the Protocol Steering Committee. Requests can be made to the Committee (via the Principal Investigators).
Query!
What supporting documents are/will be available?
No Supporting Document Provided
Results publications and other study-related documents
No documents have been uploaded by study researchers.
Results not provided in
https://clinicaltrials.gov/study/NCT04383652